DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer
Status:
Terminated
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to study DPPE combined with epirubicin and cyclophosphamide in
patients with metastatic and/or recurrent breast cancer who may have received previous
hormone treatment but have not had exposure to anthracycline treatment. Stratification
allocation will be within the following subgroups:
1. Prior cytotoxic treatment;
2. Estrogen receptor status;
3. ECOG performance status;
4. Number of cycles of chemotherapy.